Form 8-K - Current report:
SEC Accession No. 0001193125-20-186885
Filing Date
2020-07-02
Accepted
2020-07-02 16:31:48
Documents
12
Period of Report
2020-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d947796d8k.htm   iXBRL 8-K 27647
  Complete submission text file 0001193125-20-186885.txt   146608

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrna-20200629.xsd EX-101.SCH 3072
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20200629_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20200629_pre.xml EX-101.PRE 10954
5 EXTRACTED XBRL INSTANCE DOCUMENT d947796d8k_htm.xml XML 3228
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 201009865
SIC: 2836 Biological Products, (No Diagnostic Substances)